Crescent Biopharma, Inc.CBIONASDAQ
LOADING
|||
Cash Flow Performance
Trending lower, below historical average, strong compound growth.
Left:
||||
Free cash flow yield
Latest
-1.94%
↓ 363% below average
Average (9y)
-0.42%
Historical baseline
Range
High:-0.06%
Low:-1.94%
CAGR
+42.8%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | -1.94% | -729.9% |
| 2023 | -0.23% | +20.2% |
| 2022 | -0.29% | +62.3% |
| 2021 | -0.78% | -239.4% |
| 2020 | -0.23% | -0.4% |
| 2019 | -0.23% | -103.8% |
| 2018 | -0.11% | -83.6% |
| 2017 | -0.06% | +74.1% |
| 2016 | -0.23% | -199.9% |
| 2015 | -0.08% | - |